i think the key here is the MC. OBJ for example, has been rated...

i think the key here is the MC. OBJ for example, has been rated between 3 to 6 times HTX in the last couple of weeks. as have ADO, VLA etc... this should get closer to 65mill MC if not 100 mill coz:

1. Springtree investment - they know their stuff in the biotech space. if they are investing close to 20 mill - they surely think this is worth atleast 5 times that?

2. Real Sales to start! - no speccie

3. Awarded by its peers recently due to real commercial potential and sophistication of product.

4. CEO targeting 20% of global tests (including the US) in the next 24 months.

all in all, give it a PE of even 8 and we are way over the 250 million MC. but for now, lets say 60 mill... the sp has a way to go. if it doesnt happen now, it will be a hold for me.